Clinical trials
Irritable Bowel Syndrome trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Recruiting | 6 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sahlgrenska University Hospital | 16 |
| Karolinska Institutet | 10 |
| Örebro University, Sweden | 5 |
| Region Skane | 4 |
| Uppsala University | 4 |
| Menarini Group | 2 |
| Region Örebro County | 2 |
| Celgene | 1 |
| GlaxoSmithKline | 1 |
| Glycom A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Irritable Bowel Syndrome | 58 |
| Gastrointestinal Diseases | 5 |
| Abdominal Pain | 4 |
| Constipation | 2 |
| Diarrhea | 2 |
| Dilatation, Pathologic | 2 |
| Dyspepsia | 2 |
| Inflammation | 2 |
| Intestinal Diseases | 2 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.